Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.
Looking for a particular ExcellGene SA employee's phone or email?
ExcellGene SA Questions
The ExcellGene SA annual revenue was $4 million in 2026.
Maria Wurm is the CEO, Member of the Board of Directors of ExcellGene SA.
49 people are employed at ExcellGene SA.
ExcellGene SA is based in Monthey, Valais.
The NAICS codes for ExcellGene SA are [541, 54, 541713, 5417, 54171].
The SIC codes for ExcellGene SA are [873, 87].
Top ExcellGene SA Employees
-
3
-
Joseph Jammal
CEO at ExcellGene SA
Lyon, FR13 -
Martin Schmid
CFO at ExcellGene SA
Montreux, VD, CH33 -
Divor Kiseljak
Chief Technology Officer at ExcellGene SA
Lausanne, VD, CH1 -
31 -
1
-
Lucien Delapraz
Head of HR at ExcellGene SA
Vevey, VD, CH2 -
Paco Pino
Director R and D at ExcellGene SA
Monthey, VS, CH1 -
Uday Ulhe
Director - Business Development APAC at ExcellGene SA
Monthey, VS, CH3 -
Stéphanie Anchisi
Head of Cell Line Development at ExcellGene SA
Abondance, Auvergne-Rhône-Alpes, FR1
